Plasma protein binding of risperidone and its distribution in blood
- 1 May 1994
- journal article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 114 (4), 566-572
- https://doi.org/10.1007/bf02244986
Abstract
The plasma protein binding of the new antipsychotic risperidone and of its active metabolite 9-hydroxy-risperidone was studied in vitro by equilibrium dialysis. Risperidone was 90.0% bound in human plasma, 88.2% in rat plasma and 91.7% in dog plasma. The protein binding of 9-hydroxy-risperidone was lower and averaged 77.4% in human plasma, 74.7% in rat plasma and 79.7% in dog plasma. In human plasma, the protein binding of risperidone was independent of the drug concentration up to 200 ng/ml. The binding of risperidone increased at higher pH values. Risperidone was bound to both albumin andα 1-acid glycoprotein. The plasma protein binding of risperidone and 9-hydroxy-risperidone in the elderly was not significantly different from that in young subjects. Plasma protein binding differences between patients with hepatic or renal impairment and healthy subjects were either not significant or rather small. The blood to plasma concentration ratio of risperidone averaged 0.67 in man, 0.51 in dogs and 0.78 in rats. Displacement interactions of risperidone and 9-hydroxy-risperidone with other drugs were minimal.Keywords
This publication has 18 references indexed in Scilit:
- Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjectsClinical Pharmacology & Therapeutics, 1993
- Methods of Determining Plasma and Tissue Binding of DrugsClinical Pharmacokinetics, 1992
- Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative studyActa Psychiatrica Scandinavica, 1992
- Pilot Clinical Investigation of Risperidone in the Treatment of Psychotic PatientsPharmacopsychiatry, 1990
- Disease-Induced Variations in Plasma Protein LevelsClinical Pharmacokinetics, 1990
- Protein Binding Drug Displacement InteractionsClinical Pharmacokinetics, 1989
- Effects of Development, Aging, and Renal and Hepatic Insufficiency as well as Hemodialysis on the Plasma Concentrations of Albumin and α1-Acid GlycoproteinTherapeutic Drug Monitoring, 1986
- Alpha1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsyEuropean Journal of Clinical Pharmacology, 1985
- Imipramine serum protein binding in healthy subjectsCancer Cell, 1983
- Protein Binding Displacement Interactions and their Clinical ImportanceDrugs, 1983